Propriedades psicométricas do WHODAS para uso em pessoas com chikungunya no Brasil
DOI:
https://doi.org/10.1590/1809-2950/18036226042019Palavras-chave:
Febre de Chikungunya, Classificação Internacional de Funcionalidade, Incapacidade e Saúde, Saúde Pública, FisioterapiaResumo
O objetivo deste estudo é validar um instrumento de aferição da funcionalidade segundo a proposta conceitual da Classificação Internacional de Funcionalidade, Incapacidade e Saúde, para uso em pessoas pós-chikungunya. Este é um estudo de validação com indivíduos >17 anos, de ambos os sexos, em atendimento para manejo clínico da chikungunya. A coleta de dados foi realizada por meio de entrevistas coletando informações sobre funcionalidade (WHODAS), qualidade de vida (WHOQOL-bref) e sociodemográficas. A análise estatística usou o coeficiente alfa de Cronbach (consistência interna) e coeficiente de correlação de Spearman (validade convergente), médias e desvios-padrão para a determinação do perfil de qualidade de vida, com nível de significância de 5%. A amostra foi composta por 68 indivíduos. Os valores médios das pontuações dos instrumentos foram: 45,4 (±16,38) para o WHODAS e 12,1 (±2,10) para o WHOQOL-bref. O alfa de Cronbach do valor total foi de α=0,93; todos os domínios do WHODAS apresentaram valores acima de 0,75. O valor total do WHODAS 2.0 apresentou forte correlação com o domínio físico (r=−0,74) e moderada correlação com os domínios psicológico (r=−0,68) e social (r=−0,42) do WHOQOL-bref. Os resultados indicam que o WHODAS 2.0 é um instrumento válido para a mensuração da autopercepção de alteração da funcionalidade em pacientes acometidos pela chikungunya, capaz de fornecer dados que podem ajudar a construir um perfil de impacto da doença no perfil de funcionalidade dessa população.
Downloads
Referências
Paul BJ, Sadanand S. Chikungunya infection: a re-emerging
epidemic. Rheumatol Ther. 2018;5(2):317-26. doi:10.1007/
s40744-018-0121-7
Azevedo RSS, Oliveira CS, Vasconcelos PFC. Chikungunya
risk for Brazil. Rev Saude Pública. 2015;49:58. doi:10.1590/
S0034-8910.2015049006219
Nunes MRT, Faria NR, Vasconcelos JM, Golding N, Kraemer
MUG, Oliveira LF, et al. Emergence and potential for spread
of Chikungunya virus in Brazil. BMC Med. 2015;13(1):102. doi:
https://doi.org/10.1186/s12916-015-0348-x
van Aalst M, Nelen CM, Goorhuis A, Stijnis C, Grobusch MP.
Long-term sequelae of chikungunya virus disease: a systematic
review. Travel Med Infect Dis. 2017;15:8-22. doi: 10.1016/j.
tmaid.2017.01.004
Vijayan V, Sukumaran S. Chikungunya virus disease: an
emerging challenge for the rheumatologist. J Clin Rheumatol.
;22(4):203-11. doi: 10.1097/RHU.0000000000000396
Couturier E, Guillemin F, Mura M, Leon L, Virion JM, Letort MJ, et al.
Impaired quality of life after chikungunya virus infection: a 2-year
follow-up study. Rheumatology (Oxford). 2012;51(7):1315-22.
doi: 10.1093/rheumatology/kes015
Hossain MS, Hasan M, Islam MS, Islam S, Mozaffor M, Khan
MAS, et al. Chikungunya outbreak (2017) in Bangladesh: clinical
profile, economic impact and quality of life during the acute
phase of the disease. PLoS Negl Trop Dis. 2018;12(6): e0006561.
doi: 10.1371/journal.pntd.0006561
World Health Organization [Internet]. International classification
of functioning, disability and health (ICF). Genebra; 2003
[cited 2019 Sept 18]. Available from: https://www.who.int/
classifications/en/
Stucki G, Bickenbach J. Functioning: the third health indicator
in the health system and the key indicator for rehabilitation.
Eur J Phy Rehabil Med. 2017;53(1):134-8. doi: 10.23736/
S1973-9087.17.04565-8
Castro SS, Leite CF [Internet]. Avaliação de Saúde e Deficiência:
Manual do WHO Disability Assessment Schedule (WHODAS 2.0).
Uberaba: Organização Mundial da Saúde [cited 2019 Sept 18];
Available from: https://apps.who.int/iris/bitstream/hand
le/10665/43974/9788562599514_por.pdf;jsessionid=C14D1E0
FF1008AEDFE1E68D2B4DD?sequence=19
Brasil. Portaria nº 204, de 17 de fevereiro de 2016. Diário Oficial
da União [Internet]. 18 Fev. 2016 [cited 2019 Sept 18];1:23.
Available from: http://bvsms.saude.gov.br/bvs/saudelegis/
gm/2016/prt0204_17_02_2016.html
Castro SS, Leite CF. Translation and cross-cultural adaptation
of the World Health Organization Disability Assessment
Schedule – WHODAS 2.0. Fisioter Pesqui. 2017;24(4):385-91.
doi: 10.1590/1809-2950/17118724042017
Garin O, Ayuso-Mateos JL, Almansa J, Nieto M, Chatterji S,
Vilagut G, et al. Validation of the “World Health Organization
Disability Assessment Schedule, WHODAS-2” in patients with
chronic diseases. Health Qual Life Outcomes. 2010;8:51. doi:
1186/1477-7525-8-51
Kutlay S, Küçükdeveci AA, Elhan AH, Oztuna D, Koç N, Tennant
A. Validation of the World Health Organization Disability
Assessment Schedule II (WHODAS-II) in patients with
osteoarthritis. Rheumatol Int. 2011;31(3):339-46. doi: 10.1007/
s00296-009-1306-8
Baron M, Schieir O, Hudson M, Steele R, Kolahi S, Berkson L, et al.
The clinimetric properties of the World Health Organization
Disability Assessment Schedule II in early inflammatory arthritis.
Arthritis Rheum. 2008;59(3):382-90. doi: 10.1002/art.23314
Meesters JJL, Verhoef J, Liem ISL, Putter H, Vliet Vlieland TP.
Validity and responsiveness of the World Health Organization
Disability Assessment Schedule II to assess disability in
rheumatoid arthritis patients. Rheumatology (Oxford).
;49(2):326-33. doi: 10.1093/rheumatology/kep369
Magistrale G, Pisani V, Argento O, Incerti CC, Bozzali M,
Cadavid D, et al. Validation of the World Health Organization
disability assessment schedule II (WHODAS-II) in patients
with multiple sclerosis. Mult Scler. 2015;21(4):448-56. doi:
1177/1352458514543732
Hudson M, Steele R, Taillefer S, Baron M, Canadian Scleroderma
Research Group. Quality of life in systemic sclerosis:
psychometric properties of the World Health Organization
Disability Assessment Schedule II. Arthritis Rheum.
;59(2):270-8. doi: 10.1002/art.23343
Cheung MK, Hung AT, Poon PK, Fong DY, Li LS, Chow ES,
et al. Validation of the World Health Organization Assessment
Schedule II Chinese traditional version (WHODAS II CT) in
persons with disabilities and chronic illnesses for Chinese
population. Disabil Rehabil. 2015;37(20):1902-7. doi:
3109/09638288.2014.989336
Park SH, Demetriou EA, Pepper KL, Song YJC, Thomas EE,
Hickie IB, et al. Validation of the 36-item and 12-item Self-Report
World Health Organization Disability Assessment Schedule II
(WHODAS-II) in individuals with autism spectrum disorder.
Autism Res. 2019;12(7)1101-11. doi: 10.1002/aur.2115
Ćwirlej-Sozańska A, Wilmowska-Pietruszyńska A, Sozański
B. Validation of the Polish version of the World Health
Organization Disability Assessment Schedule (WHODAS 2.0)
in an elderly population (60-70 years old). Int J Occup Saf
Ergon. 2018;24(3):386-94. doi: 10.1080/10803548.2017.1316596
Habtamu K, Alem A, Medhin G, Fekadu A, Dewey M, Prince M,
Hanlon C. Validation of the World Health Organization Disability
Assessment Schedule in people with severe mental disorders
in rural Ethiopia. Health Qual Life Outcomes. 2017;15(1):64. doi:
1186/s12955-017-0647-3
Küçükdeveci AA, Kutlay Ş, Yıldızlar D, Öztuna D, Elhan AH,
Tennant A. The reliability and validity of the World Health
Organization Disability Assessment Schedule (WHODASII) in stroke. Disabil Rehabil. 2013;35(3):214-20. doi:
3109/09638288.2012.690817
Chiu TY, Finger ME, Fellinghauer CS, Escorpizo R, Chi WC, Liou
T-H, et al. Validation of the World Health Organization Disability
Assessment Schedule 2.0 in adults with spinal cord injury in
Taiwan: a psychometric study. Spinal Cord. 2019;57(6):516-24.
doi:10.1038/s41393-018-0231-7
Barbosa KSS, Castro SS, Leite CF, Nacci FR, Accioly MF. Validation
the Brazilian version of World Health Organization Disability
Assessment Schedule 2.0 for people HIV/aids. Cienc Saude Coletiva.
:386. Available from: http://www.cienciaesaudecoletiva.com.
br/artigos/validacao-da-versao-brasileira-do-world-healthorganization-disability-assessment-schedule-20-em-individuoshivaids/16919?id=16919&id=16919
Castro SS, Leite CF, Baldin JE, Accioly MF. Validation of the Brazilian
version of WHODAS 2.0 in patients on hemodialysis therapy.
Fisioter Mov. 2018;31:e003130. doi: 10.1590/1980-5918.031.ao30
Skevington SM, Lotfy M, O’Connell KA, WHOQOL Group.
The World Health Organization’s WHOQOL-BREF quality
of life assessment: psychometric properties and results of
the international field trial. A report from the WHOQOL
group. Qual Life Res. 2004;13(2):299-310. doi: 10.1023/B:QU
RE.0000018486.91360.00
The World Health Organization quality of life assessment
(WHOQOL): development and general psychometric
properties. Soc Sci Med. 1998;46(12):1569-85.doi: 10.1016/
S0277-9536(98)00009-4
Fleck MP, Louzada S, Xavier M, Chachamovich E, Vieira G,
Santos L, Pinzon V. Aplicação da versão em português do
instrumento abreviado de avaliação da qualidade de vida
“WHOQOL-bref”. Rev Saude Publica. 2000;34(2):178-83. doi:
1590/S0034-89102000000200012
Cronbach LJ. Coefficient alpha and the internal structure of tests.
Psychometrika. 1951;16(3):297-334. doi: 10.1007/BF02310555
Brito CAA, von Sohsten AKA, Leitão CCS, Brito RCCM, Azevedo
Valadares LD, Fonte CAM, et al. Pharmacologic management of
pain in patients with Chikungunya: a guideline. Rev Soc Bras Med
Trop. 2016;49(6):668-79. doi:10.1590/0037-8682-0279-2016
Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int
J Med Educ. 2011;2:53-5. doi: 10.5116/ijme.4dfb.8dfd
Chiu TY, Yen CF, Chou CH, Lin JD, Hwang AW, Liao HF, Chi WC.
Development of traditional Chinese version of World Health
Organization Disability Assessment Schedule 2.0 36-item
(WHODAS 2.0) in Taiwan: validity and reliability analyses. Res
Dev Disabil. 2014;35(11):2812-20. doi:10.1016/j.ridd.2014.07.009
Wolf AC, Tate RL, Lannin NA, Middleton J, Lane-Brown A,
Cameron ID. The World Health Organization Disability
Assessment Scale, WHODAS II: reliability and validity in the
measurement of activity and participation in a spinal cord
injury population. J Rehabil Med. 2012;44(9):747-55. doi:
2340/16501977-1016
Fisioter Pesqui. 2019;26(4):419-426
McKibbin C, Patterson TL, Jeste D V. Assessing disability in
older patients with schizophrenia results from the WHODAS-II.
J Nerv Ment Dis. 2004;192(6):405-13.doi: 10.1097/01.
nmd.0000130133.32276.83
Snell DL, Iverson GL, Panenka WJ, Silverberg N
Downloads
Publicado
Edição
Seção
Licença
Copyright (c) 2019 Ana Jéssica dos Santos Sousa, Maria Caroline da Silva, Marina Carvalho Arruda Barreto, Bárbara Porfírio Nunes, Bernardo Diniz Coutinho, Shamyr Sulyvan de Castro
Este trabalho está licenciado sob uma licença Creative Commons Attribution-ShareAlike 4.0 International License.
